For small and medium regional markets generic drugs business of marketing promotion strategy.docVIP

For small and medium regional markets generic drugs business of marketing promotion strategy.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
For small and medium regional markets generic drugs business of marketing promotion strategy

 PAGE \* MERGEFORMAT 15 For small and medium regional markets generic drugs business of marketing promotion strategy According to authoritative statistics, China now been GMP-certified pharmaceutical companies among the nearly 7000, almost 90% of the enterprises to SMEs, from 2005 onwards, for two consecutive years of domestic drug sales statistics, 10 percent of large enterprise sales account for the country’s total plate more than 30%, 90% of small and medium enterprises accounted for about 70% of the total plate, with a continuous loss-making enterprises which account for the proportion of small and medium enterprises is still a huge decline in the profit of enterprises which also occupy the mainstream of small and medium enterprises. From the above data it is clear that small and medium enterprises in which the current difficult living environment and living space, leaving the small and medium enterprises will become increasingly narrow path! 1, small and medium enterprises operating status of generic drugs For SMEs, the brand does not have the brand, both channels of the brand or the brand and the general public does not have an advantage compared to large enterprises. In product prices due to the size constraints, can not do low-cost competition, but there can not be selling the brand, so prices are often in a relatively awkward position. In terms of varieties, the conventional generic drugs products are the main, relatively low profit, high degree of homogenization of serious, but do not have the ability to develop new drugs and inputs, in the variety of competition does not have a competitive advantage. The people who use on the relatively limited resources of small and medium enterprises can not effectively attract a large number of high-quality talent to join, while the talent is to ensure business success or failure of the most important factor. In financial strength, after a GMP certification costs almost exhausted the limited hardware costs

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档